Concepedia

Jingxuan Liu

JL

Statistics

Publications

13

Citations

667

H-Index

13

Active since

2005

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Stony Brook University

Stony Brook University Hospital

Fudan University

Jingxuan Liu is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, cell biology, and pathology.

ORCID

Top concepts

Publications per year

2005–2021

13

Publications

13

Transforming activity of MECT1‐MAML2 fusion oncoprotein is mediated by constitutive CREB activation

Lizi Wu, Jingxuan Liu, Ping Gao et al. · The EMBO Journal · 2005 · 135 citations · Full text

5′‐(<i>E</i>)‐Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA–GalNAc Conjugates

Rubina Parmar, Jennifer L. S. Willoughby, Jingxuan Liu et al. · ChemBioChem · 2016 · 132 citations

Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates

Maja M. Janas, Ivan Zlatev, Ju Liu et al. · Nucleic Acids Research · 2019 · 77 citations · Full text

, , +12

Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer

Sen Yao, Xuqian Li, Jingxuan Liu et al. · Drug Delivery · 2017 · 63 citations · Full text

Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma

Joseph M. Catanzaro, Jennifer L. Guerriero, Jingxuan Liu et al. · PLoS ONE · 2011 · 54 citations · Full text

, , +15

1–5 of 13